Feature|Videos|March 31, 2026
Veridix Document Authoring: Your AI Co-Author for Clinical Documents
Author(s)Nageswara Kollu, Veridix, part of Emmes Group
Key Takeaways
- Identify how AI tools can alleviate the workload of small discovery teams by automating preclinical documentation, reducing costs, and increasing the speed of IND submissions.
- Examine strategies for maintaining consistency across global regulatory filings by using AI to standardize reports from various CROs into uniform formats for different regional requirements.
Nageswara Kollu, Senior Director at Apellis Pharmaceuticals, explains how the discovery team leverages AI to automate preclinical documentation and regulatory filings, improving consistency and achieving significant time savings in the drug development process.
Faced with the challenge of managing complex workflows with a lean team, Apellis Pharmaceuticals is utilizing AI to standardize preclinical reports and streamline global IND submissions. This integration of technology reduces manual writing burdens and costs while ensuring the high level of quality and consistency necessary for diverse regulatory environments. By maintaining a "human-in-the-loop" approach, the discovery team can move beyond repetitive documentation to focus on critical data analysis and scientific decision-making.
Related Content
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention
3
SCOPE X: What Real-Time Patient Data Is Doing to ClinOps Efficiency
4
ACT Brief: AI-Driven Enrollment Results, Statistician Standards in Early Phase, and RNA Editing for Kidney Disease
5